On-chip PCR amplification of genomic and viral templates in unprocessed whole blood
Performing medical diagnosis in microfluidic devices could scale down laboratory functions and reduce the cost for accessible healthcare. The ultimate goal of such devices is to receive a sample of blood, perform genetic amplification (polymerase chain reaction—PCR) and subsequently analyse the amplified products. DNA amplification is generally performed with DNA purified from blood, thus requiring on-chip implementation of DNA extraction steps with consequent increases in the complexity and cost of chip fabrication. Here, we demonstrate the use of unprocessed whole blood as a source of template for genomic or viral targets (human platelet antigen 1 (HPA1), fibroblast growth factor receptor 2 (FGFR2) and BK virus (BKV)) amplified by PCR on a three-layer microfluidic chip that uses a flexible membrane for pumping and valving. The method depends upon the use of a modified DNA polymerase (Phusion™). The volume of the whole blood used in microchip PCR chamber is 30 nl containing less than 1 ng of genomic DNA. For BKV on-chip whole blood PCR, about 3000 copies of BKV DNA were present in the chamber. The DNA detection method, laser-induced fluorescence, used in this article so far is not quantitative but rather qualitative providing a yes/no answer. The ability to perform clinical testing using whole blood, thereby eliminating the need for DNA extraction or sample preparation prior to PCR, will facilitate the development of microfluidic devices for inexpensive and faster clinical diagnostics.
KeywordsOn-chip PCR Microfluidics Whole blood PCR Phusion Taq
This work was supported by an Interdisciplinary Team Grant from the Alberta Heritage Foundation for Medical Research (AHFMR). LMP is the Canada Research Chair in Biomedical Nanotechnology and this work was funded in part by the Chair’s program. We thank Dr. Xiao-Li Pang, Provincial Laboratories for Public Health, Edmonton, Alberta for providing BKV DNA and Paul R. Dumais for the fabrication of the chips.
- ABI (2009) DNA sequencing by capillary electrophoresis. Applied Biosystems Chemistry GuideGoogle Scholar
- Adamia S, Reichert AA, Kuppusamy H, Kriangkum J, Ghosh A, Hodges JJ, Pilarski PM, Treon SP, Mant MJ, Reiman T, Belch AR, Pilarski LM (2008) Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia. Blood 112:5111–5121CrossRefGoogle Scholar
- Akane A, Matsubara K, Nakamura H, Takahashi S, Kimura K (1994) Identification of the heme compound copurified with deoxyribonucleic-acid (DNA) from bloodstains, a major inhibitor of polymerase chain-reaction (PCR) amplification. J Forensic Sci 39:362–372Google Scholar
- Chia BT, Yang XY, Cheng MY, Yang YJ (2010) A DNA extraction and polymerase-chain-reaction microchip using magnetic beads and thermo-pneumatic valves. Mems 2010: 23rd IEEE international conference on micro electro mechanical systems, Technical Digest, pp 967–970Google Scholar
- Higuchi R (1989) PCR technology: principles and applications for DNA amplification. Stockton Press, New YorkGoogle Scholar